Geode Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$141M Sell
1,915,616
-344,447
-15% -$25.4M 0.01% 821
2025
Q1
$259M Buy
2,260,063
+191,888
+9% +$22M 0.02% 560
2024
Q4
$104M Sell
2,068,175
-310,583
-13% -$15.7M 0.01% 974
2024
Q3
$110M Buy
2,378,758
+99,470
+4% +$4.6M 0.01% 926
2024
Q2
$74.1M Buy
2,279,288
+121,503
+6% +$3.95M 0.01% 1106
2024
Q1
$54.4M Buy
2,157,785
+112,139
+5% +$2.83M 0.01% 1297
2023
Q4
$66.4M Buy
2,045,646
+87,959
+4% +$2.86M 0.01% 1147
2023
Q3
$53.3M Buy
1,957,687
+212,897
+12% +$5.8M 0.01% 1192
2023
Q2
$38.8M Sell
1,744,790
-49,137
-3% -$1.09M ﹤0.01% 1417
2023
Q1
$38.9M Buy
1,793,927
+72,426
+4% +$1.57M 0.01% 1360
2022
Q4
$35M Buy
1,721,501
+74,718
+5% +$1.52M ﹤0.01% 1395
2022
Q3
$42.2M Buy
1,646,783
+17,306
+1% +$444K 0.01% 1201
2022
Q2
$38.7M Sell
1,629,477
-37,403
-2% -$889K 0.01% 1294
2022
Q1
$37.5M Sell
1,666,880
-63,992
-4% -$1.44M ﹤0.01% 1453
2021
Q4
$34.3M Sell
1,730,872
-74,533
-4% -$1.48M ﹤0.01% 1592
2021
Q3
$35.5M Sell
1,805,405
-3,905
-0.2% -$76.9K ﹤0.01% 1562
2021
Q2
$39.8M Buy
1,809,310
+38,105
+2% +$838K 0.01% 1502
2021
Q1
$42.1M Buy
1,771,205
+123,882
+8% +$2.95M 0.01% 1364
2020
Q4
$43.1M Buy
1,647,323
+135,198
+9% +$3.54M 0.01% 1211
2020
Q3
$26.3M Sell
1,512,125
-11,829
-0.8% -$206K 0.01% 1323
2020
Q2
$25.6M Buy
1,523,954
+44,693
+3% +$752K 0.01% 1317
2020
Q1
$17.6M Buy
1,479,261
+46,655
+3% +$555K ﹤0.01% 1390
2019
Q4
$17.3M Buy
1,432,606
+16,207
+1% +$196K ﹤0.01% 1655
2019
Q3
$20M Buy
1,416,399
+31,927
+2% +$451K ﹤0.01% 1489
2019
Q2
$15.4M Buy
1,384,472
+124,903
+10% +$1.39M ﹤0.01% 1662
2019
Q1
$14.8M Buy
1,259,569
+84,535
+7% +$992K ﹤0.01% 1628
2018
Q4
$15.7M Buy
1,175,034
+85,705
+8% +$1.14M ﹤0.01% 1453
2018
Q3
$15.3M Buy
1,089,329
+110,170
+11% +$1.54M ﹤0.01% 1607
2018
Q2
$15.4M Buy
979,159
+100,904
+11% +$1.59M ﹤0.01% 1547
2018
Q1
$14.4M Sell
878,255
-67,095
-7% -$1.1M ﹤0.01% 1504
2017
Q4
$17.1M Sell
945,350
-17,607
-2% -$318K 0.01% 1377
2017
Q3
$18.6M Buy
962,957
+98,635
+11% +$1.9M 0.01% 1296
2017
Q2
$10.2M Buy
864,322
+24,127
+3% +$285K ﹤0.01% 1651
2017
Q1
$9.21M Buy
840,195
+77,945
+10% +$854K ﹤0.01% 1676
2016
Q4
$5.53M Buy
762,250
+99,478
+15% +$722K ﹤0.01% 2008
2016
Q3
$4.31M Buy
662,772
+124,974
+23% +$812K ﹤0.01% 2064
2016
Q2
$2.94M Buy
537,798
+43,650
+9% +$238K ﹤0.01% 2223
2016
Q1
$2.31K Sell
494,148
-191
-0% -$1 ﹤0.01% 2358
2015
Q4
$2.46M Buy
494,339
+10,719
+2% +$53.4K ﹤0.01% 2332
2015
Q3
$1.82M Buy
483,620
+38,147
+9% +$143K ﹤0.01% 2508
2015
Q2
$2.68M Buy
445,473
+2,722
+0.6% +$16.4K ﹤0.01% 2313
2015
Q1
$2.48M Buy
442,751
+22,608
+5% +$127K ﹤0.01% 2308
2014
Q4
$1.26M Sell
420,143
-31,632
-7% -$94.8K ﹤0.01% 2705
2014
Q3
$1.21M Buy
451,775
+38,211
+9% +$102K ﹤0.01% 2674
2014
Q2
$1.16M Buy
413,564
+61,180
+17% +$171K ﹤0.01% 2714
2014
Q1
$1.54M Buy
352,384
+55,908
+19% +$244K ﹤0.01% 2504
2013
Q4
$954K Buy
296,476
+61,658
+26% +$198K ﹤0.01% 2747
2013
Q3
$373K Buy
234,818
+7,583
+3% +$12K ﹤0.01% 3077
2013
Q2
$393K Buy
+227,235
New +$393K ﹤0.01% 2982